Who is sponsoring NCT04707430?

NCT04707430 is sponsored by Sezcan Mumusoglu.

What drugs are being tested in NCT04707430?

Interventions in NCT04707430: blood progesterone test.

What condition does NCT04707430 study?

NCT04707430 studies Relationship of Progesterone Levels and Pregnancy.

Is NCT04707430 still recruiting?

NCT04707430 is currently completed. Last updated 17 March 2022.

Last reviewed 2022-03-17 · How we verify

NCT04707430

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

The Effect of Progesterone Levels on Pregnancy

Completed Last updated 17 March 2022

What this trial tests

trial testing blood progesterone test in Relationship of Progesterone Levels and Pregnancy in 156 participants. Completed in 1 August 2021.

Timeline

1 August 2020

Primary endpoint
1 May 2021

1 August 2021

Quick facts

Lead sponsor	Sezcan Mumusoglu
Status	Completed
Study type	OBSERVATIONAL
Enrollment	156
Start date	1 August 2020
Primary completion	1 May 2021
Estimated completion	1 August 2021
Sites	1 location across Turkey (Türkiye)

Drugs / interventions tested

blood progesterone test

Conditions studied

Relationship of Progesterone Levels and Pregnancy — all drugs for Relationship of Progesterone Levels and Pregnancy →

Sponsor

Sezcan Mumusoglu

Who can join

Under 40, female only, with Relationship of Progesterone Levels and Pregnancy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to investigate the effect of progesterone levels on pregnancy occurrence on the 3rd and 5th days after insemination.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04707430 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Sezcan Mumusoglu
Last refreshed: 17 March 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04707430.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing